Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activationCecilia T. Costiniuk, Mohammad‐Ali Jenabian|BMJ Open|2019Cited by 46
Prevalence and Characterization of Subclinical Coronary Atherosclerotic Plaque with CT among Individuals with HIV: Results from the Canadian HIV and Aging Cohort StudyIrina Boldeanu, Alexander Wong, Cécile Tremblay et al.|Radiology|2021Cited by 37
Correction: Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite ControllersMohammad‐Ali Jenabian, Jean‐Pierre Routy, M.H. Patel et al.|PLoS ONE|2014Cited by 3
Soluble CD40 Ligand Plays an Immunosuppressive Role in HIV Infection via IDO-Induced Tryptophan Catabolism, Treg Expansion and Microbial TranslocationMohammad‐Ali Jenabian, Jean‐Pierre Routy, M.H. Patel et al.|Data Archiving and Networked Services (DANS)|2013Cited by 0